Product/Composition:- | Venetoclax |
---|---|
Strength:- | 10 mg, 50 mg, 100 mg |
Form:- | Tablet |
Reference Brands:- | Venclexta® (EU & US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Venetoclax Tablets (brand name Venclexta®) are oral BCL-2 inhibitors used for treating CLL, SLL, and AML. Available in 10 mg, 50 mg, and 100 mg strengths, they are manufactured under GMP standards and approved in US and EU markets, offering a reliable oncology solution.
Venetoclax Tablets are a targeted oral therapy used in the treatment of hematologic malignancies such as chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and acute myeloid leukemia (AML). As a potent BCL-2 inhibitor, Venetoclax promotes apoptosis in cancer cells by restoring programmed cell death pathways. Marketed under the brand name Venclexta®, it is available in 10 mg, 50 mg, and 100 mg strengths. Manufactured under GMP-certified facilities, Venetoclax offers a reliable oncology solution for B2B pharmaceutical partners across the US and EU, supporting effective cancer treatment strategies with proven clinical outcomes.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications